Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-25

FDA Approved: TAZAROTENE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved the original ANDA for tazarotene (TAZAROTENE) by Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAZAROTENE (TAZAROTENE)

Snippet

ORIG AP for TAZAROTENE (TAZAROTENE)